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Summary
This thesis describes the results of the research we performed to address the problems of genotypic and phenotypic variation and genotype-phenotype correlations in four Mendelian disorders of cornification (MEDOC): mal de Meleda (MDM), Epidermolytic Ichthyosis (EI), Darier disease (DD) and Hailey-Hailey disease (HHD).
Chapter II discusses the clinical and genetic aspects of mal de Meleda (MDM).
This autosomal recessive palmoplantar keratoderma (PPK) is caused by mutations in the Secreted Ly-6/uPar related protein-1 (SLURP1). It is defined by a progressive transgredient hyperkeratosis of the palms and soles, hyperhidrosis, malodourous scent due to bacterial superinfection and minor symptoms such as perioral erythema, mild ichthyosiform hyperkeratosis on elbows and knees, pseudo-ainhum and nail abnormalities. To assess clinical and genotypic variability in MDM, we summarised all phenotypes reported in the literature and created a semi-quantative disease scoring system that can be used in further research. We described the phenotype and genotype of four Dutch families, one German and one Indian family with MDM, in whom we found heterozygosity for the p. We performed haplotype analysis in MDM patients with the p.(Trp15Arg) variant and found a shared core haplotype of 125 Kbp segregating with p.(Trp15Arg), indicating a founder effect. With the results of our literature study, we re-evaluate the conclusions of a recent report that described p.(Trp15Arg) variants in SLURP1 in palmoplantar keratoderma of the Gamborg-Nielsen type (PPK-GN). The authors consider PPK-GN to be a separate disease allelic to MDM. We argue that the PPK-GN phenotype represents the milder end of the disease severity spectrum of MDM and that PPK-GN is not therefore a separate disease entity.
Chapter III describes clinical variance in Epidermolytic Ichthyosis (EI), which is a rare autosomal dominant skin disorder caused by mutations in the genes coding for keratin 1 (KRT1) and 10 (KRT10). Mutations associated with a severe phenotype (widespread blistering and erythroderma during infancy that develops into generalised ichthyosis) affect the helix boundary motifs (HBM) of the protein. Mutations causing milder phenotypes (blistering upon mechanical trauma, but no ichthyosis) occur in the central α-helical region (1B, 2B) and linker (L12) domain. We describe a large family with EI in whose affected members we found the p.(Met339Lys) mutation in the L12 domain of KRT1 associated with a remarkable intrafamilial phenotypic variation. The index patient presented with a diffuse palmoplantar keratoderma and severe ichthyosis, in absence of congenital blistering and erythroderma. The other patients, having the same mutation and sharing a common ancestor with the first patient, only developed a diffuse palmoplantar keratoderma and occasionally friction blisters. HaCaT cells expressing the mutant p.(Met339Lys) EGFP-KRT1 fusion construct showed increased keratin clumping compared to wild-type transfected cells, supporting pathogenicity of the p. (Met339Lys) variant. We speculate on the probable mechanisms that underlie the intrafamilial differences in EI phenotype, but are unable to explain this observed difference.
Chapter IV describes clinical and genetic variability in the two disorders of cornification associated with mutations in genes coding for intracellular calcium pumps:
Darier disease (DD) and Hailey-Hailey disease (HHD). Both are inherited as autosomal dominant traits. DD is mainly defined by warty papules in seborrheic and flexural areas and associated with mutations in the ATP2A2 gene, whereas the major symptoms of HHD are vesicles and erosions in flexural skin, caused by ATP2C1 mutations. Both phenotypes are highly variable. 12-40% of DD patients and 12-55% of HHD patients have no mutations in ATP2A2 (DD) or ATP2C1 (HHD). We describe two DD patients with a less frequently encountered phenotype. The first patient is a 1-year-old Caucasian boy with type II segmental DD, in whom we found the p.(Gly343Asp) mutation in ATP2A2. We were able to provide molecular genetic support for the type II segmental manifestation in DD, which has not been done before. The second patient was a 25-yearold female, born in Sri Lanka, with unusually mild DD caused by a missense mutation p.(Leu590Pro). We hypothesise that the skin type of our patient holds the key to the mild appearance of the disease. We also commented on the observed high prevalence of depression and depressive symptoms in DD. We argue that this may be the result of the psychological burden of a chronic skin disease, rather than a neuropsychiatric manifestation of SERCA2b dysfunction and advocate a more clinically oriented approach towards psychiatric and psychological care in DD. We reviewed all reported mutations in ATP2A2 and ATP2C1 and created a database for all mutations in ATP2A2 and ATP2C1 duplications. This is further illustrated by the fact that we found skipping of exon 4 of ATP2A2 by RNA analysis in a DD patient, in whom we were unable to identify ATP2A2 variants using conventional diagnostic strategies. Alternatively, DD and HHD could be caused by mutations in other genes that give rise to comparable phenotypes. We could not discern a specific genotype-phenotype correlation between disease severity, disease course and mutation type or location in DD and HHD. There is limited data that suggests that a correlation between mutations in the ATP-binding region of SERCA2 could be associated with the development of Acrokeratosis Verruciformis of Hopf (AKV).
Chapter V reflects on the findings described in the previous chapters and addresses the aims of this thesis as put forward in the introduction. This thesis extends our knowledge on clinical and genetic variability in MEDOC. Considering clinical variability, we were either able to show that our observations are in concordance with earlier reports (MDM, DD, HHD) or are able to describe unusual features not previously reported (intrafamilial variation in EI, type II segmental disease in DD and a mild DD phenotype in a patient with skintype V). Considering genetic variability, we significantly expand the mutation spectrum in MDM, EI, DD and HHD. With regard to genotype-phenotype correlations, we can conclude that genotype-phenotype correlations in EI are not always as strong as thought. Our data suggests a probable genotype-phenotype correlation in AKV. In MDM, DD and HHD, no other relation than segregation of variants with the disease phenotype was observed. The limitations of this study are the absence of reliable disease scoring systems to objectively evaluate disease phenotypes. This compromises the establishment of genotype-phenotype correlations and the fact that we are unable to explain the pathophysiologic mechanisms underlying our observations. However, our findings are a relevant contribution to patient care and management in MEDOC. de gehele genen en worden alle type mutaties gezien. In de patiënten met DD en HHD, bij wie we geen mutatie in het aangedane gen vinden, kunnen andere genetische defecten aanwezig zijn, die we met de door ons gebruikte methode niet aan kunnen tonen. In een DD patiënt vonden we bij analyse van het RNA (nadat het "klassieke" DNA onderzoek
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